Literature DB >> 1534909

Inactivation of gram-negative bacteria by photosensitized porphyrins.

Y Nitzan1, M Gutterman, Z Malik, B Ehrenberg.   

Abstract

Photosensitization of Escherichia coli and Pseudomonas aeruginosa cells by deuteroporphyrin (DP) is shown to be possible in the presence of the polycationic agent polymyxin nonapeptide (PMNP). Previous studies established complete resistance of Gram-negative bacteria to the photodynamic effects of porphyrins. The present results show that combined treatment of E. coli or P. aeruginosa cultures with DP and PMNP inhibit cell growth and viability. No antibacterial activity of PMNP alone could be demonstrated and cell viability remained unchanged. Spectroscopically, PMNP was found to bind DP, a mechanism which probably assists its penetration into the cell's membranes. Insertion of DP into the cells was monitored by the characteristic fluorescence band of bound DP at 622 nm. Binding times were 5-40 min and the extent of binding increased with decreasing the pH from 8.5 to 6.5. DP binding constants, as well as the concentrations of PMNP which were required for maximal effect on the various Gram-negative bacteria, were determined fluorometrically. By the treatment of DP, PMNP and light the growth of E. coli and P. aeruginosa cultures was stopped and the viability of the culture was dramatically reduced. Within 60 min of treatment the survival fraction of E. coli culture was 9 x 10(-6) and that of P. aeruginosa was 5.2 x 10(-4). Electron microscopy depicted ultrastructural alterations in the Gram-negative cells treated by DP and PMNP. The completion of cell division was inhibited and the chromosomal domain was altered markedly.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1534909     DOI: 10.1111/j.1751-1097.1992.tb04213.x

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN: 0031-8655            Impact factor:   3.421


  72 in total

1.  Immune response after photodynamic therapy increases anti-cancer and anti-bacterial effects.

Authors:  Eleonora Reginato; Peter Wolf; Michael R Hamblin
Journal:  World J Immunol       Date:  2014-03-27

2.  Photodynamic therapy: a new antimicrobial approach to infectious disease?

Authors:  Michael R Hamblin; Tayyaba Hasan
Journal:  Photochem Photobiol Sci       Date:  2004-02-12       Impact factor: 3.982

3.  Effects of growth phase and extracellular slime on photodynamic inactivation of gram-positive pathogenic bacteria.

Authors:  Faten Gad; Touqir Zahra; Tayyaba Hasan; Michael R Hamblin
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

Review 4.  Photodynamic therapy targeted to pathogens.

Authors:  T N Demidova; M R Hamblin
Journal:  Int J Immunopathol Pharmacol       Date:  2004 Sep-Dec       Impact factor: 3.219

5.  Chitosan augments photodynamic inactivation of gram-positive and gram-negative bacteria.

Authors:  Tsuimin Tsai; Hsiung-Fei Chien; Tze-Hsien Wang; Ching-Tsan Huang; Yaw-Bee Ker; Chin-Tin Chen
Journal:  Antimicrob Agents Chemother       Date:  2011-01-31       Impact factor: 5.191

6.  Inhibitors of bacterial multidrug efflux pumps potentiate antimicrobial photoinactivation.

Authors:  George P Tegos; Kayo Masago; Fatima Aziz; Andrew Higginbotham; Frank R Stermitz; Michael R Hamblin
Journal:  Antimicrob Agents Chemother       Date:  2008-05-12       Impact factor: 5.191

7.  Photodynamic therapy as an adjunctive treatment for chronic periodontitis: a meta-analysis.

Authors:  Momen A Atieh
Journal:  Lasers Med Sci       Date:  2009-12-19       Impact factor: 3.161

Review 8.  Can light-based approaches overcome antimicrobial resistance?

Authors:  Michael R Hamblin; Heidi Abrahamse
Journal:  Drug Dev Res       Date:  2018-08-02       Impact factor: 4.360

9.  meso-Tetra(pentafluorophenyl)porphyrin as an efficient platform for combinatorial synthesis and the selection of new photodynamic therapeutics using a cancer cell line.

Authors:  Diana Samaroo; Mikki Vinodu; Xin Chen; Charles Michael Drain
Journal:  J Comb Chem       Date:  2007-09-15

10.  Photodynamic Therapy for Cancer and for Infections: What Is the Difference?

Authors:  Sulbha K Sharma; Pawel Mroz; Tianhong Dai; Ying-Ying Huang; Tyler G St Denis; Michael R Hamblin
Journal:  Isr J Chem       Date:  2012-09       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.